GENE ONLINE|News &
Opinion
Blog

2022-07-11| R&DTechnology

Alleviating Depression and Dementia with Transcorneal Electrical Stimulation

by Fujie Tham
Share To

A joint research team in Hong Kong discovered that stimulation of the eye surface can reduce depressive symptoms and improve cognitive functions in animals, leading to the possibilities of novel therapeutic applications for patients with chronic depression and neurological diseases such as Alzheimer’s

The scientists from LKS Faculty of Medicine, University of Hong Kong, and City University of Hong Kong published their findings in Brain Stimulation and Annals of the New York Academy of Sciences, as a result of the effort to develop alternative neuropsychiatric diseases treatments without the need of invasive deep brain stimulation.

Instead of implanting electrodes into the brain, the team achieved therapeutic effects by a non-invasive stimulation of the eye’s corneal surface (transcorneal electrical stimulation, TES), the technique resulted in antidepressant-like effects and reduced stress hormones in an animal model. Additionally, this technique induced gene expression involved in the development and growth of brain cells in the hippocampus, a region crucial for memory and learning.

Related article: BIO 2022: Challenges in Developing Cell and Gene Therapies

 

Electrical Stimulation of Eye May Cure Alzheimer’s 

 

Alongside encouraging hippocampal cells’ growth, the scientists observed that TES reduced beta-amyloid buildups, a characteristic of Alzheimer’s disease in a related study. Dr. Leanne Chan Lai-hang, co-author of this research shared: “Transcorneal electrical stimulation is a non-invasive method initially developed to treat eye diseases, and it would be a major scientific breakthrough if it could be applied to treat neuropsychiatric diseases.”

Treatment with TES effectively reduced blood stress hormone (corticosterone) levels in stressed test subjects, while upregulating neurogenesis-related markers. The team found that the expression of neurogenesis-related gene Ki67 is lower in stressed rats, subsequent treatment by TES restored expression to normal level.

“These research findings pave the way for new therapeutic opportunities to develop novel treatment for patients suffering from treatment-resistant depression and dementia. Nevertheless, clinical trials must be conducted to validate the efficacy and safety,” said Professor Chan Ying-shing.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Revolutionary Wristband Sensor Technology Predicts Alzheimer’s Risk
2024-01-04
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
LATEST
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top